Broker tips: Astra, Tullow, Miners
8th Jul 2009 12:02
Producers of generic alternatives to AstraZeneca's prostate cancer drug Casodex have been slow off the mark and this has created an unexpected windfall for the UK drugs giant. US drugs firms Mylan and Caraco received approval from the US Food and Drugs Administration (FDA) yesterday to start shippi
Read moreBroker snap: Astra to profit from rivals' tardiness
8th Jul 2009 12:01
Producers of generic alternatives to AstraZeneca's prostate cancer drug Casodex have been slow off the mark, and this has created an unexpected windfall for the UK drugs giant, Panmure Gordon reckons. US drugs firms Mylan and Caraco received approval from the US Food and Drugs Administration (FDA)
Read moreThursday tips round-up: AstraZeneca, Morgan Sindall, Afren
2nd Jul 2009 06:14
Yesterday's failed blockbuster drug can be tomorrow's niche therapy. That would appear to be the prognosis from AstraZeneca, which yesterday won European marketing approval for Iressa, its once-a-day lung cancer pill. Longer-term challenges remain: notably the tide of patent expiries, such as the 2
Read moreLondon close: Footsie adds 2%
1st Jul 2009 16:34
Miners were rampant Wednesday on stronger commodity prices, leaving the sector heavyweights dominating the blue chip index. There was healthy demand for gold on the metal markets, while copper also improved. The red metal headed higher following strong Chinese manufacturing data, while decreasing s
Read moreLondon afternoon: Resource stocks lead the way
1st Jul 2009 14:29
Resource stocks lead the market higher after the second half of the year got off to a good start following better than expected factory output data. The CIPS/Markit manufacturing purchasing managers' index rose to 47 in June from 45.4 the month before and a gloomy 34.9 in February. Most of the top
Read moreLondon midday: Marks sparks rally
1st Jul 2009 12:06
A well received set of results from Marks & Sparks and the strength of miners drives London higher today. Marks and Spencer's like-for-like sales fell across its major divisions in the first quarter, though total group sales were up. In the 13-weeks to June, UK like for like sales fell 1.4%, Genera
Read moreLondon open: Footsie strongly ahead
1st Jul 2009 08:50
It is all blue this morning so far with demand for miners adding to well received trading statements from Marks & Spencer and International Power. Bus and rail group National Express is the big story. It has handed back the East Coast franchise after failing to renegotiate terms. The service will n
Read moreLondon pre-open: Slight advance expected
1st Jul 2009 07:47
Footsie is tipped to edge higher in early dealings. Marks and Spencer's saw like-for-like sales fall across its major divisions in the first quarter, though total group sales were up. In the 13-weeks to June, UK like for like sales fell 1.4%, General Merchandise slipped 2.4% and Food was down 0.5%.
Read moreAstraZeneca's Iressa gets EU marketing approval
1st Jul 2009 07:24
AstraZeneca has received EU marketing approval for its lung cancer treatment Iressa four years after its was withdrawn from use after disappointing trial data. AstraZeneca said approval has been granted by the European Commission for the treatment of adults with locally advanced or metastatic non-s
Read moreLondon close: Stocks finish in the red
26th Jun 2009 16:25
London's leading shares finished in the red by close as Wall Street remained in negative territory. Insurer were down with Friends Provident, Prudential and Legal & General lower while miners Eurasian Natural Resources, Rio Tinto and Vedanta were also down. The banks are in a healthier condition
Read moreLondon afternoon: Footsie in red
26th Jun 2009 14:13
London has slipped into negative territory, led by insurers and some wayward miners, while Wall Street is seen starting lower. Friends Provident, Prudential and Legal & General are among the biggest fallers, joined by Eurasian Natural Resources, Rio Tinto and Vedanta. The banks are in a healthier
Read moreLondon midday: Shares crawl higher
26th Jun 2009 12:18
Risers outnumber fallers by two to one among Footsie constituents but the benchmark index is barely in positive territory, as some of the heavily weighted constituents feature among the laggards. The banks are in a healthier condition than six months ago but are still vulnerable to more economic sh
Read moreLondon open: Blue chips move higher
26th Jun 2009 09:02
London's blue chips have opened higher as Wall Street closed up 2% last night and after some reassuring comments about the banks from the Bank of England. The banks are in a healthier condition than six months ago but are still vulnerable to more economic shocks, the Bank of England said in its la
Read moreLondon pre-open: Footsie points higher
26th Jun 2009 07:36
London's blue chips look set to open higher after Wall Street closed up 2% last night. Traders expect Footsie to gain 35 points in early dealings. London-listed drugs giant AstraZeneca and US pharmaceuticals major Bristol-Myers Squibb said their jointly developed treatment for type 2 diabetes has c
Read moreAstra's diabetes drug a step closer to EU release
26th Jun 2009 07:34
London-listed drugs giant AstraZeneca and US pharmaceuticals major Bristol-Myers Squibb said their jointly developed treatment for type 2 diabetes has cleared a regulatory hurdle in Europe. Astra said its marketing authorisation application for ONGLYZA (saxagliptin) was received positively by the C
Read more